Skip to main content

Table 1 Highlighting individual patient characteristics (age; gender) including initial diagnosis (histology; TNM-stage disease, tumour features)

From: Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

  Absolute n Percentage %
Age years
 < 60 years 20 43.4
 ≥ 60 years 26 56.6
Gender
Female 12 26.1
Male 34 73.9
Histology
Adenocarcinoma 12 26.1
Squamous-cell carcinoma 33 71.7
Non other specified 1 2.2
TNM-stage disease
T4 N0 M0 34 73.9
T4 N1 M0 12 26.1
Clinical performance status Absolute n Percentage %
ECOG-Status
ECOG 0 27 58.7
ECOG 1 18 39.1
ECOG 2 1 2.2
NYHA-Class
No cardiac insufficiency 32 69.6
NYHA 1 10 21.7
NYHA 2 4 8.7
COPD-Score (GOLD)
No pulmonary obstruction 17 36.9
COPD 1 5 10.9
COPD 2 20 43.5
COPD 3 3 6.5
COPD 4 1 2.2
  Absolute n Percentage %
Operable 17 36.9
Functional non-operable 25 54.4
Technical non-operable 4 8.7
Total 46 pts 100%
Tumor characteristics Mean Range
Grading 2.5 1–4
PD-L1 [%] 27.25 [12 pts tested] 0–100
Post-CTx MTV 61.7 [29 pts] 0.2–265.2
SUVmax 4.1 2.0–13.8